JGC
CORZ

J. Goldman & Co’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

J. Goldman & Co’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,113,025
Closed -$11.3M – 484
2021
Q3 		$11.3M Buy
+1,113,025
New +$11.2M 0.56% 47

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

J. Goldman & Co's CORZ Position: Q4 2021 in Review

J. Goldman & Co sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2021, closing a stake of 1,113,025 shares — an estimated $11.3M sold.

J. Goldman & Co first reported a position in CORZ in Q3 2021 and held it in 1 quarter. The position peaked at $11.3M in Q3 2021. 71 funds tracked by Wall St. Rank hold CORZ as of Q4 2021.

  • J. Goldman & Co reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • J. Goldman & Co sold 1,113,025 Core Scientific, Inc. Common Stock shares in Q4 2021, an estimated $11.3M.
  • J. Goldman & Co first reported a position in Core Scientific, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • J. Goldman & Co's Core Scientific, Inc. Common Stock position peaked at $11.3M in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2021.

Based on J. Goldman & Co's 13F filing for Q4 2021, filed 14 Feb 2022.